Virginia Catalyst Announces $2.1 Million Awarded

RICHMOND, VA – October 26, 2020 – The Virginia Catalyst today announced that it has awarded $2.1 million in grants to three life and bioscience projects in the Commonwealth of Virginia. These grants, which will be met with significant matching funds from partner companies, were awarded as Round 11 of Virginia Catalyst’s ongoing mission to stimulate economic development by promoting collaborative projects that address large, unmet needs for improving human health, and that can create high-paying jobs in the Commonwealth.

Round 11 of grant funding project winners:
Project: Clinical Translation of a Male Contraceptive Procedure

• Company: Contraline, Inc. (Charlottesville, VA)
• University collaborators: University of Virginia and Virginia Commonwealth University
• Funding amount: $600,000

Project: Treating chronic Disease Caused by Microbiome Dysbiosis

• Company: ISOThrive, Inc. (Manassas, VA)
• University collaborators: George Mason University, Eastern Virginia Medical School, and University of Virginia
• Funding amount: $800,000

Project: Innovative Bioanalytical Instrument for Improving Drug Discovery

• Company: Meru Biotechnologies (Richmond, VA)
• University collaborators: Virginia Commonwealth University and Old Dominion University
• Funding amount: $700,000

Read the full press release here